Publications

Dugdale CM, Ufio O, Alba C, Permar SR, Stranix-Chibanda L, Cunningham CK, Fouda GG, Myer L, Weinstein MC, Leroy V et al..  2023.  Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings.. J Int AIDS Soc. 26(1):e26052.

Berendam SJ, Nelson AN, Yagnik B, Goswami R, Styles TM, Neja MA, Phan CT, Dankwa S, Byrd AU, Garrido C et al..  2022.  Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure.. Front Immunol. 13:885272.

Yunga STassi, Siriwardhana C, Fouda GG, Bobbili N, Sama G, Chen JJ, Leke RFG, Taylor DWallace.  2022.  Characterization of the primary antibody response to Plasmodium falciparum antigens in infants living in a malaria-endemic area.. Malar J. 21(1):346.

Semmes EC, Li SHang, Hurst JH, Yang Z, Niedzwiecki D, Fouda GG, Kurtzberg J, Walsh KM, Permar SR.  2022.  Congenital Human Cytomegalovirus Infection Is Associated With Decreased Transplacental IgG Transfer Efficiency Due to Maternal Hypergammaglobulinemia.. Clin Infect Dis. 74(7):1131-1140.

Lucier A, Fong Y, Li SHang, Dennis M, Eudailey J, Nelson A, Saunders K, Cunningham CK, McFarland E, McKinney R et al..  2022.  Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency Virus.. J Infect Dis. 225(10):1731-1740.

Uffman EA, Li SHang, Chen J-L, Allen N, Boiditswe S, Fouda GG, Hurst JH, Patel MZ, Steenhoff AP, Cunningham CK et al..  2022.  Kinetics of pneumococcal antibodies among HIV-exposed, uninfected infants in Botswana.. Vaccine. 40(33):4764-4771.

Semmes EC, Miller IG, Wimberly CE, Phan CT, Jenks JA, Harnois MJ, Berendam SJ, Webster H, Hurst JH, Kurtzberg J et al..  2022.  Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection.. J Clin Invest. 132(16)

Chen J-L, Fries CN, Berendam SJ, Rodgers NS, Roe EF, Wu Y, Li SHang, Jain R, Watts B, Eudailey J et al..  2022.  Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation.. Sci Adv. 8(38):eabq0273.

Curtis AD, Saha PT, Dennis M, Berendam SJ, Ramasubramanian P, Cross KA, S Alam M, Ferrari G, Kozlowski PA, Fouda GG et al..  2022.  Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection.. mSphere. 7(1):e0083921.

Tu JJ, Kumar A, Giorgi EE, Eudailey J, LaBranche CC, Martinez DR, Fouda GG, Moreau Y, Thomas A, Montefiori D et al..  2022.  Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.. J Virol. 96(11):e0023122.

Fries CN, Curvino EJ, Chen J-L, Permar SR, Fouda GG, Collier JH.  2021.  Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health.. Nat Nanotechnol. 16(4):1-14.

Garrido C, Hurst JH, Lorang CG, Aquino JN, Rodriguez J, Pfeiffer TS, Singh T, Semmes EC, Lugo DJ, Rotta AT et al..  2021.  Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents.. JCI Insight. 6(17)

Berendam SJ, Morgan-Asiedu PK, Mangan RJ, Li SHang, Heimsath H, Luo K, Curtis AD, Eudailey JA, Fox CB, Tomai MA et al..  2021.  Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques.. PLoS One. 16(12):e0256885.

Obregon-Perko V, Bricker KM, Mensah G, Uddin F, Rotolo L, Vanover D, Desai Y, Santangelo PJ, Jean S, Wood JS et al..  2021.  Dynamics and origin of rebound viremia in SHIV-infected infant macaques following interruption of long-term ART.. JCI Insight. 6(23)

Fries CN, Chen J-L, Dennis ML, Votaw NL, Eudailey J, Watts BE, Hainline KM, Cain DW, Barfield R, Chan C et al..  2021.  HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth.. Sci Rep. 11(1):14494.

Mangold JF, Goswami R, Nelson AN, Martinez DR, Fouda GG, Permar SR.  2021.  Maternal Intervention to Prevent Mother-to-Child Transmission of HIV: Moving Beyond Antiretroviral Therapy.. Pediatr Infect Dis J. 40(5S):S5-S10.

Fouda GGA, Kwiek JJ, Yotebieng M.  2021.  Safety of Breastfeeding by Mothers With COVID-19: New Evidence From Israel.. Pediatrics. 147(5)

Berendam SJ, Styles TM, Morgan-Asiedu PK, Tenney DA, Kumar A, Obregon-Perko V, Bar KJ, Saunders KO, Santra S, De Paris K et al..  2021.  Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency Viruses.. J Virol. 95(3)

Post AL, Li SHang, Berry M, Itell H, Martinez DR, Xie G, Permar SR, Swamy GK, Fouda GG.  2020.  Efficiency of placental transfer of vaccine-elicited antibodies relative to prenatal Tdap vaccination status.. Vaccine. 38(31):4869-4876.

Goswami R, Berendam SJ, Li SHang, Nelson AN, De Paris K, Van Rompay KKA, Permar SR, Fouda GG.  2020.  Harnessing early life immunity to develop a pediatric HIV vaccine that can protect through adolescence.. PLoS Pathog. 16(11):e1008983.

Fouda GG, De Paris K, Levy O, Marchant A, Gray G, Permar S, Marovich M, Singh A.  2020.  Immunological mechanisms of inducing HIV immunity in infants.. Vaccine. 38(3):411-415.

Hompe ED, Mangold JF, Kumar A, Eudailey JA, McGuire E, Haynes BF, M Moody A, Wright PF, Fouda GG, Giorgi EE et al..  2020.  Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials.. mSphere. 5(3)

Singh T, Heston SM, Langel SN, Blasi M, Hurst JH, Fouda GG, Kelly MS, Permar SR.  2020.  Lessons From COVID-19 in Children: Key Hypotheses to Guide Preventative and Therapeutic Strategies.. Clin Infect Dis. 71(8):2006-2013.

Berendam SJ, Nelson AN, Goswami R, Persaud D, Haigwood NL, Chahroudi A, Fouda GG, Permar SR.  2020.  Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.. Curr HIV/AIDS Rep. 17(3):237-248.

Blasi M, Fouda GG.  2020.  Shortening HIV vaccine regimens to achieve high coverage.. Lancet HIV. 7(6):e377-e378.